Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
Cellular Immunology
|
February 1, 1988
Role of macrophages in bypassing the inhibitory activity of Newcastle disease virus on the T-suppressor-cell circuit which regulates contact sensitivity to picryl chloride
F Dieli, S Abrignani, D Lio, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
August 31, 1984
[Activation of the alternative complement pathway by Newcastle disease virus. II) Effects mediated by infected lymphoid cells in vitro]
A Salerno, G Colonna Romano, S Abrignani, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
August 31, 1984
[Activation of the alternative complement pathway by Newcastle disease virus. I) Effect of the virus on the complement system in vivo and in vitro]
F Dieli, G Gallina, S Abrignani, et al.
Virus Research
|
October 13, 2001
The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor
F Masciopinto, S Campagnoli, S Abrignani, et al.
Nature
|
August 11, 1988
T cells can present antigens such as HIV gp120 targeted to their own surface molecules
A Lanzavecchia, E Roosnek, T Gregory, et al.
Cellular Immunology
|
August 1, 1985
Infection of mice with Newcastle disease virus inhibits the T suppressor afferent cell circuit which regulates contact sensitivity to picryl chloride
F Dieli, G Colonna Romano, S Abrignani, et al.
Immunology
|
March 1, 1986
Inhibition of lymphocyte mitogenesis in mice infected with Newcastle disease virus: viral interference with the interleukin system
G Colonna Romano, F Dieli, S Abrignani, et al.
The Journal of Experimental Medicine
|
February 1, 1988
Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets
A Lanzavecchia, S Abrignani, D Scheidegger, et al.
AIDS (London, England)
|
December 22, 1999
Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice
S Toneatto, O Finco, H van der Putten, et al.
European Journal of Immunology
|
February 13, 2001
Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells
A Wack, E Soldaini, C Tseng, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
Cellular Immunology
|
February 1, 1988
Role of macrophages in bypassing the inhibitory activity of Newcastle disease virus on the T-suppressor-cell circuit which regulates contact sensitivity to picryl chloride
F Dieli, S Abrignani, D Lio, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
August 31, 1984
[Activation of the alternative complement pathway by Newcastle disease virus. II) Effects mediated by infected lymphoid cells in vitro]
A Salerno, G Colonna Romano, S Abrignani, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
August 31, 1984
[Activation of the alternative complement pathway by Newcastle disease virus. I) Effect of the virus on the complement system in vivo and in vitro]
F Dieli, G Gallina, S Abrignani, et al.
Virus Research
|
October 13, 2001
The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor
F Masciopinto, S Campagnoli, S Abrignani, et al.
Nature
|
August 11, 1988
T cells can present antigens such as HIV gp120 targeted to their own surface molecules
A Lanzavecchia, E Roosnek, T Gregory, et al.
Cellular Immunology
|
August 1, 1985
Infection of mice with Newcastle disease virus inhibits the T suppressor afferent cell circuit which regulates contact sensitivity to picryl chloride
F Dieli, G Colonna Romano, S Abrignani, et al.
Immunology
|
March 1, 1986
Inhibition of lymphocyte mitogenesis in mice infected with Newcastle disease virus: viral interference with the interleukin system
G Colonna Romano, F Dieli, S Abrignani, et al.
The Journal of Experimental Medicine
|
February 1, 1988
Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets
A Lanzavecchia, S Abrignani, D Scheidegger, et al.
AIDS (London, England)
|
December 22, 1999
Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice
S Toneatto, O Finco, H van der Putten, et al.
European Journal of Immunology
|
February 13, 2001
Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells
A Wack, E Soldaini, C Tseng, et al.
Page
of 6